Dr. James Glenn Peters, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14724 Highway 15 N, Louisville, MS 39339 Phone: 662-773-7500 |
Dr. Samuel Keith Suttle, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14724 Highway 15 N, Louisville, MS 39339 Phone: 662-773-7500 |
James D Gentry, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17540 E Main St, Louisville, MS 39339 Phone: 662-773-3503 Fax: 662-773-6457 |
Dr. Roger L Nunez, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14130 Highway 15 S Ste D, Louisville, MS 39339 Phone: 662-779-1175 Fax: 844-778-8922 |
Dr. Michael L. Ard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17540 E Main Street, Louisville, MS 39339 Phone: 662-773-3503 Fax: 662-446-1039 |
News Archive
HOYA ConBio, a global leader in dental and aesthetic lasers, today announced an agreement with The Las Vegas Institute for Advanced Dental Studies (LVI) Global, an internationally renowned provider of post-graduate dental education, to feature premium dental lasers at LVI Global's first branch in Brisbane, Australia. Effective November 1, this new partnership builds on HOYA ConBio's long-standing involvement at LVI Global's headquarters in Las Vegas.
A recent publication, which received sustained media attention, claimed that most cancers are just "bad luck". Its authors stated that only about one-third of cancer mutations are caused by known lifestyle or environmental factors.
Researchers hope to one day use stem cells to heal burns, patch damaged heart tissue, even grow kidneys and other transplantable organs from scratch.
Research teams from three academic institutions and two private sector companies on two continents have come together to form the International malaria research consortium for the development of novel classes of antimalarials. This bold initiative will develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments.
The model will permit to accelerate and reduce the price of the research, which is studying the mechanisms and the possible pharmacological targets for the neuronal alterations of this disease.
› Verified 7 days ago